Page last updated: 2024-10-22

albuterol and Anemia, Hemolytic

albuterol has been researched along with Anemia, Hemolytic in 1 studies

Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Anemia, Hemolytic: A condition of inadequate circulating red blood cells (ANEMIA) or insufficient HEMOGLOBIN due to premature destruction of red blood cells (ERYTHROCYTES).

Research Excerpts

ExcerptRelevanceReference
" Albuterol is known to induce myocardial ischemia."7.73Albuterol-induced myocardial ischemia in sickle cell anemia after hemolysis from ceftriaxone administration. ( Corso, M; Ravindranath, TM, 2005)
" Albuterol is known to induce myocardial ischemia."3.73Albuterol-induced myocardial ischemia in sickle cell anemia after hemolysis from ceftriaxone administration. ( Corso, M; Ravindranath, TM, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Corso, M1
Ravindranath, TM1

Other Studies

1 other study available for albuterol and Anemia, Hemolytic

ArticleYear
Albuterol-induced myocardial ischemia in sickle cell anemia after hemolysis from ceftriaxone administration.
    Pediatric emergency care, 2005, Volume: 21, Issue:2

    Topics: Adrenergic beta-Agonists; Albuterol; Anemia, Hemolytic; Anemia, Sickle Cell; Ceftriaxone; Child; Hum

2005